CA2114311A1 - Lignee cellulaire monoclonale de lymphocytes b wb - Google Patents

Lignee cellulaire monoclonale de lymphocytes b wb

Info

Publication number
CA2114311A1
CA2114311A1 CA2114311A CA2114311A CA2114311A1 CA 2114311 A1 CA2114311 A1 CA 2114311A1 CA 2114311 A CA2114311 A CA 2114311A CA 2114311 A CA2114311 A CA 2114311A CA 2114311 A1 CA2114311 A1 CA 2114311A1
Authority
CA
Canada
Prior art keywords
cells
protein
cell
cell line
magnification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2114311A
Other languages
English (en)
Other versions
CA2114311C (fr
Inventor
Richard Kian-Hock Wee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002114311A priority Critical patent/CA2114311C/fr
Publication of CA2114311A1 publication Critical patent/CA2114311A1/fr
Application granted granted Critical
Publication of CA2114311C publication Critical patent/CA2114311C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002114311A 1991-11-25 1991-11-25 Lignee cellulaire monoclonale de lymphocytes b wb Expired - Fee Related CA2114311C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002114311A CA2114311C (fr) 1991-11-25 1991-11-25 Lignee cellulaire monoclonale de lymphocytes b wb

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002114311A CA2114311C (fr) 1991-11-25 1991-11-25 Lignee cellulaire monoclonale de lymphocytes b wb

Publications (2)

Publication Number Publication Date
CA2114311A1 true CA2114311A1 (fr) 1993-05-26
CA2114311C CA2114311C (fr) 1996-02-27

Family

ID=4152799

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002114311A Expired - Fee Related CA2114311C (fr) 1991-11-25 1991-11-25 Lignee cellulaire monoclonale de lymphocytes b wb

Country Status (1)

Country Link
CA (1) CA2114311C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792278A1 (fr) * 1994-11-07 1997-09-03 Human Genome Sciences, Inc. Polypeptide gamma appartenant a la famille des facteurs de necrose tumorale (fnt)
US6599719B2 (en) 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
US6824767B2 (en) 1994-11-07 2004-11-30 Human Genome Sciences, Inc. Tumor necrosis factor-gamma

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792278A1 (fr) * 1994-11-07 1997-09-03 Human Genome Sciences, Inc. Polypeptide gamma appartenant a la famille des facteurs de necrose tumorale (fnt)
EP0792278A4 (fr) * 1994-11-07 1999-09-22 Human Genome Sciences Inc Polypeptide gamma appartenant a la famille des facteurs de necrose tumorale (fnt)
US6599719B2 (en) 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
US6824767B2 (en) 1994-11-07 2004-11-30 Human Genome Sciences, Inc. Tumor necrosis factor-gamma

Also Published As

Publication number Publication date
CA2114311C (fr) 1996-02-27

Similar Documents

Publication Publication Date Title
Van Furth Mononuclear phagocytes: functional aspects
Yamaguchi et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
Grimm et al. Immunoregulation by parenteral lipids: impact of the n‐3 to n‐6 fatty acid ratio
Razin et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
Andersson et al. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.
Sato et al. Production of interleukin 1α-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis
WO1996006929A3 (fr) Procede de developpement rapide ('rem') pour la propagation des lymphocytes t in vitro
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
WO1994011026A3 (fr) Application therapeutique d'anticorps chimeriques et radio-marques contre l'antigene a differentiation restreinte des lymphocytes b humains pour le traitement du lymphome des cellules b
DeMarco et al. Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes
CA2114311A1 (fr) Lignee cellulaire monoclonale de lymphocytes b wb
Pistoia et al. Production of colony-stimulating activity by normal and neoplastic human B lymphocytes
Romagnani et al. Direct induction of human B-cell differentiation by recombinant interleukin-2.
Tanaka et al. Zinc inhibits pokeweed mitogen-induced development of immunoglobulin-secreting cells through augmentation of both CD4 and CD8 cells
Fiehn et al. Selective enhancement of endothelial cell VCAM‐1 expression by interleukin‐10 in the presence of activated leucocytes
Elkins et al. Constitutive production of a factor supporting B lymphocyte differentiation by a T cell hybridoma.
GR3018632T3 (en) Beta-alethine use in cell culture and therapy.
Mukaida et al. Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2.
Harada et al. Hematologic recovery following autologous and allogeneic bone marrow transplantation
Corcione et al. B-cell-derived granulocyte-colony stimulating factor (G-CSF)
Unsgaard Immuno‐inductive and immuno‐suppressive influence of human mononuclear phagocytes cultured in vitro
Górski et al. Thymosin: an immunomodulator of antibody production in man.
Zighelboim et al. Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells
Ohta et al. Thymosin-α1 Increases the Capability to Produce Interleukin-3 but Not Interleukin-2 in nu/nu Mice
Crockard et al. Circulating T-cell subpopulations in lithium-associated granulocytosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed